Kieran and Brennan O'Dea
Edasalonexent: Understanding DHA in DMD
Overview: Catabasis's understanding of Duchenne Muscular Dystrophy (DMD) and Edasalonexent's role in treating the disease is...
top of page
Our Research
Search
The information contained in these research pieces is intended for information purposes only. By opening these research pieces you confirm your agreement that the information herein is not investment advice or recommendations by Hedge Knight Capital but the personal views and opinions of Kieran and Brennan O'Dea. These research pieces are intended as a catalyst for conversation and debate between investment professionals. No reliance may be placed for any purpose on the information and opinions contained in these research pieces. No representation, warranty or undertaking, express or implied is given as to the accuracy or completeness of the information in these research pieces.
bottom of page